Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
$45.40
+4.1%		$38.11
$7.68
▼
$47.84
$2.73B2.21592,689 shs638,865 shs
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$18.34
+0.1%		$17.84
$11.09
▼
$21.01
$370.52M1.32456,708 shs137,065 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
+1.68%+9.00%+17.80%-0.16%+439.06%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
-0.16%-0.05%-0.22%+14.07%+41.91%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
$45.40
+4.1%		$38.11
$7.68
▼
$47.84
$2.73B2.21592,689 shs638,865 shs
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$18.34
+0.1%		$17.84
$11.09
▼
$21.01
$370.52M1.32456,708 shs137,065 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
+1.68%+9.00%+17.80%-0.16%+439.06%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
-0.16%-0.05%-0.22%+14.07%+41.91%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
2.63
Moderate Buy$48.146.04% Upside
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
1.88
Reduce$17.25-5.94% Downside

Current Analyst Ratings Breakdown

Latest KOD, LMI, SRB, and SLP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/3/2026
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$56.00 ➝ $66.00
7/10/2026
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/10/2026
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D) ➝ Sell (D+)
6/18/2026
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
Craig Hallum logo
Craig Hallum
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold$18.50
6/17/2026
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
William Blair logo
William Blair
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
6/5/2026
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D-) ➝ Sell (D)
5/21/2026
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D) ➝ Sell (D-)
5/11/2026
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
Chardan Capital logo
Chardan Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeNeutral ➝ Buy$14.00 ➝ $61.00
(Data available from 8/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
N/AN/AN/AN/A$2.97 per shareN/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$79.18M4.69$1.43 per share12.82$6.20 per share2.96
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
-$229.97M-$4.17N/AN/AN/AN/A-253.85%-81.48%8/12/2026 (Estimated)
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
-$64.72M$0.4045.85N/AN/A9.88%13.50%12.45%N/A

Latest KOD, LMI, SRB, and SLP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2026Q2 2026
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
-$0.9565N/AN/AN/AN/AN/A
7/9/2026Q3 2026
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$0.2325$0.30+$0.0675$0.18$20.90 million$21.89 million
5/7/2026Q4 2025
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
-$0.93-$0.94-$0.01-$0.94N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
N/AN/AN/AN/AN/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
N/AN/A-100.00%N/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
N/A
3.54
3.54
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
N/A
5.54
5.54

Institutional Ownership

CompanyInstitutional Ownership
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
89.06%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
78.08%

Insider Ownership

CompanyInsider Ownership
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
44.40%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
19.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
9062.58 million34.79 millionOptionable
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
16020.23 million16.36 millionOptionable

Recent News About These Companies

Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
August 6 at 10:53 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/06/3340484/0/en/johnson-fistel-investigates-simulations-plus-following-revenue-guidance-cut-and-accounting-disclosures.html
Simulations Plus, Inc. (NASDAQ:SLP) Given Average Rating of "Reduce" by Analysts
August 6 at 2:15 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30943563
Simulations Plus, Inc. (NASDAQ:SLP) Receives Consensus Recommendation of "Reduce" from Analysts
August 6 at 2:13 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/simulations-plus-inc-nasdaqslp-receives-consensus-recommendation-of-reduce-from-analysts-2026-08-06/
Simulations Plus (NASDAQ:SLP) Stock Price Passes Above 200-Day Moving Average - Here's Why
August 4 at 2:39 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/simulations-plus-nasdaqslp-stock-price-passes-above-200-day-moving-average-heres-why-2026-08-04/
Simulations Plus Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Simulations Plus, Inc. - SLP
July 30, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260730539938/en/simulations-plus-investor-alert-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-simulations-plus-inc.---slp/
Simulation Plus, Inc. Securities Fraud Investigation - Robbins LLP is Investigating Investor Losses in SLP Due to Possible Violations of Securities Laws
July 29, 2026  |  newsfilecorp.comN
SLP Shareholder Alert: Robbins LLP is Investigating Allegations that the Officers and Directors of Simulation Plus, Inc., Violated Securities Laws and Breached Fiduciary Duties to Shareholders
July 28, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/slp-shareholder-alert-robbins-llp-is-investigating-allegations-that-the-officers-and-directors-of-simulation-plus-inc-violated-securities-laws-and-breached-fiduciary-duties-to-shareholders-302837099.html
Simulation Plus, Inc. (NASDAQ: SLP) Investors Should Contact Robbins LLP for Information About Investigation
July 27, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260727420213/en/simulation-plus-inc.-nasdaq-slp-investors-should-contact-robbins-llp-for-information-about-investigation/
Simulations Plus, Inc. $SLP Stock Position Boosted by First Light Asset Management LLC
July 27, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-simulations-plus-inc-slp-stock-position-boosted-by-first-light-asset-management-llc-2026-07-27/
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
July 24, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/24/3333033/0/en/johnson-fistel-investigates-simulations-plus-following-revenue-guidance-cut-and-accounting-disclosures.html
Simulations Plus (NASDAQ:SLP) Share Price Crosses Above 200-Day Moving Average - Time to Sell?
July 21, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/simulations-plus-nasdaqslp-share-price-crosses-above-200-day-moving-average-time-to-sell-2026-07-21/
Simulations Plus: The Potential Little Spread Is Not Worth The Risk For New Money, Hold
July 20, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4923295-simulation-plus-stock-potential-spread-not-worth-the-risk-hold
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
July 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/13/3326261/0/en/johnson-fistel-investigates-simulations-plus-following-revenue-guidance-cut-and-accounting-disclosures.html
Simulations Plus, Inc. (NASDAQ:SLP) Receives Average Recommendation of "Hold" from Brokerages
July 12, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/simulations-plus-inc-nasdaqslp-receives-average-recommendation-of-hold-from-brokerages-2026-07-12/
Simulations Plus (NASDAQ:SLP) Releases FY 2026 Earnings Guidance
July 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/simulations-plus-nasdaqslp-releases-fy-2026-earnings-guidance-2026-07-10/
Simulations Plus, Inc. Q3 2026 Earnings
July 9, 2026  |  247wallst.comhttps://247wallst.com/cards/simulations-plus-inc-q3-2026-earnings-slp-01kx47y2hkyfz7jphb20t120tk
Simulations Plus (NASDAQ:SLP) Announces Earnings Results
July 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/simulations-plus-nasdaqslp-announces-earnings-results-2026-07-09/
Simulations Plus Reports Third Quarter Fiscal 2026 Financial Results
July 9, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260709321948/en/simulations-plus-reports-third-quarter-fiscal-2026-financial-results/
John Anthony Dibella II Sells 1,000 Shares of Simulations Plus (NASDAQ:SLP) Stock
July 9, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-slp-insider-buying-and-selling-2026-07-09/
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
July 8, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/08/3324198/0/en/johnson-fistel-investigates-simulations-plus-following-revenue-guidance-cut-and-accounting-disclosures.html
Simulations Plus (NASDAQ:SLP) Director Sells 4,177 Shares of Stock
July 7, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-slp-insider-buying-and-selling-2026-07-07/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Kodiak Sciences stock logo

Kodiak Sciences NASDAQ:KOD

$45.40 +1.79 (+4.10%)
Closing price 04:00 PM Eastern
Extended Trading
$45.70 +0.30 (+0.66%)
As of 06:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.

Simulations Plus stock logo

Simulations Plus NASDAQ:SLP

$18.34 +0.02 (+0.11%)
Closing price 04:00 PM Eastern
Extended Trading
$18.34 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. The company also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, RENAsym, IPFsym, and MITOsym products. In addition, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, it offers creative and insightful consulting services to support its quantitative systems pharmacology/quantitative systems toxicology modelling. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas